Autori: Kim Tae Won
Naslov | Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer (Article) |
Autori | Kim Tae Won Elme Anneli Park Joon Oh Udrea Anghel Adrian Kim Sun Young Ahn Joong Bae Valencia Ricardo Villalobos Krishnan Srinivasan Manojlovic Nebojsa S Guan Xuesong Lofton-Day Catherine Jung A Scott Vrdoljak Eduard |
Info | CLINICAL COLORECTAL CANCER, (2018), vol. 17 br. 3, str. 206-214 |
Projekat | Amgen Inc |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC). (Meeting Abstract) |
Autori | Kim Tae Won ... Kusic Zvonko ... Manojlovic Nebojsa S ... (broj koautora 16) |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2016), vol. 34 br. 15, Suppl. S, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer (Article) |
Autori | Kim Tae Won ... Manojlovic Nebojsa S ... (broj koautora 16) |
Info | BRITISH JOURNAL OF CANCER, (2016), vol. 115 br. 10, str. 1206-1214 |
Projekat | Amgen Inc. |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC. (Meeting Abstract) |
Autori | Kim Tae Won ... (broj koautora 16) |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2016), vol. 34 br. 4, Suppl. S, str. - |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|